2
|
Nakagawa S, Totsuka K, Okinaga K, Takamoto M, Ishii K. Background factors determining the time to intraocular lens dislocation. Int Ophthalmol 2024; 44:240. [PMID: 38904711 DOI: 10.1007/s10792-024-03166-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2024] [Accepted: 06/15/2024] [Indexed: 06/22/2024]
Abstract
PURPOSE To clarify the characteristics of intraocular lens (IOL) dislocation requiring IOL suture or intraocular scleral fixation. METHODS This retrospective consecutive case series included 21 eyes (21 patients) who required sutured or sutureless intrascleral IOL fixation following IOL extraction owing to IOL dislocation at the outpatient clinic in the Department of Ophthalmology, Saitama Red Cross Hospital, Japan, between January and December 2019. Medical records were retrospectively reviewed for background diseases, location of the dislocated IOL (intracapsular/extracapsular), insertion of a capsular tension ring (CTR), and the period from IOL insertion to dislocation. RESULTS We included 21 eyes of 21 patients who required IOL suture or intrascleral fixation for IOL dislocation at our clinic from January to December 2019 were included. The most common background disease was pseudoexfoliation syndrome (four cases), followed by atopic dermatitis, dysplasia/dehiscence of the zonule, post-retinal detachment surgery, high myopia, and uveitis (three cases each). At the time of dislocation, the IOLs were either intracapsular (16 cases, including 3 cases with CTR insertion) or extracapsular (5 cases). The time from IOL insertion to IOL dislocation was 13.7 ± 8.1 years (maximum: 31.3 years, minimum: 1.7 years). CONCLUSIONS In this study, all 21 cases represented late IOL dislocations occurring after 3 months postoperatively. Among these late IOL dislocation cases, IOL dislocation occurred in a short-medium period of time, especially in those with CTR insertion and weakness/dehiscence of the zonule, with an average of 3 to 5 years postoperatively. We propose referring to these cases as intermediate-term IOL dislocation.
Collapse
Affiliation(s)
- Suguru Nakagawa
- Department of Ophthalmology, Saitama Red Cross Hospital, 1-5, Shintoshin, Chuo-Ku, Saitama, Japan.
| | - Kiyohito Totsuka
- Department of Ophthalmology, Saitama Red Cross Hospital, 1-5, Shintoshin, Chuo-Ku, Saitama, Japan
| | - Kimiko Okinaga
- Department of Ophthalmology, Saitama Red Cross Hospital, 1-5, Shintoshin, Chuo-Ku, Saitama, Japan
| | - Mitsuko Takamoto
- Department of Ophthalmology, Saitama Red Cross Hospital, 1-5, Shintoshin, Chuo-Ku, Saitama, Japan
| | - Kiyoshi Ishii
- Department of Ophthalmology, Saitama Red Cross Hospital, 1-5, Shintoshin, Chuo-Ku, Saitama, Japan
| |
Collapse
|
3
|
Komatsu K, Masuda Y, Iwauchi A, Kubota H, Iida M, Ichihara K, Iwamoto M, Kawai K, Yamamoto N, Shimoda M, Nakano T. Lens capsule pathological characteristics in cases of intraocular lens dislocation with atopic dermatitis. J Cataract Refract Surg 2024; 50:611-617. [PMID: 38350154 PMCID: PMC11146175 DOI: 10.1097/j.jcrs.0000000000001413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 01/26/2024] [Accepted: 01/29/2024] [Indexed: 02/15/2024]
Abstract
PURPOSE To explore lens capsule pathological characteristics in intraocular lens (IOL) dislocation after cataract surgery in patients with atopic dermatitis (AD). SETTING University hospital department of ophthalmology. DESIGN Case series with clinicopathological correlations. METHODS Lens capsules and surrounding tissues excised during surgery from eyes with AD (AD group) and eyes without AD (non-AD group) with IOL dislocation were histologically evaluated. Hematoxylin and eosin staining was used to assess abnormal changes in lens epithelial cells (LECs). Masson trichrome staining distinguished the fibrous metaplasia around the lens capsule into high-density and low-density fibrosis. Capsular splitting (thinning) was identified in both stained preparations. RESULTS The IOL dislocation morphology in the AD group (10 eyes of 10 patients) included 7 cases of capsular bag dislocation (CBD) and 3 cases of dead bag syndrome (DBS), with an average duration to IOL dislocation of 11.5 ± 5.6 years. All patients in the non-AD group (12 eyes of 12 patients) had CBD, averaging 10.2 ± 5.7 years to dislocation. Abnormal LECs, low-density fibrosis, and capsular splitting were observed in 9 (90), 9 (90), and 6 (60) of the patients in the AD group compared with 6 (50), 3 (25), and 2 (18), respectively, in the non-AD group (total n [%]). CONCLUSIONS Compared with the non-AD group, the AD group exhibited higher frequencies of morphological changes in LECs, low-density fibrosis around the lens capsule, and capsular splitting characteristics of DBS. These results suggest LEC degeneration and increased lens capsule fragility occurred in patients with AD.
Collapse
Affiliation(s)
- Koji Komatsu
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Yoichiro Masuda
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Ai Iwauchi
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Hoshiho Kubota
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Masanobu Iida
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Kosuke Ichihara
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Masami Iwamoto
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Kenji Kawai
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Naoki Yamamoto
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Masayuki Shimoda
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| | - Tadashi Nakano
- From the Department of Ophthalmology, The Jikei University School of Medicine, Minato-ku, Tokyo, Japan (Komatsu, Masuda, Iida, Ichihara, Nakano); Department of Pathology, TheJikei University School of Medicine, Minato-ku, Tokyo, Japan (Iwauchi, Kubota, Iwamoto, Shimoda); Department of Ophthalmology, Tokai University School of Medicine, Isehara, Kanagawa, Japan (Kawai); Support Office for Bioresource Research, Center for Translational Research, Translational Research Headquarters, Fujita Health University, Toyoake, Aichi, Japan (Yamamoto)
| |
Collapse
|